Markets Ladenburg ups Avadel Pharma PT to $20 from $14 Ladenburg Thalmann raised its price target for Avadel Pharmaceuticals (NASDAQ:AVDL) to $20 from $14 after the company posted positive topline Phase 3 results for FT218, a once nightly formulation of Micropump controlled... April 28, 2020